(NASDAQ: ZLAB) Zai Lab's forecast annual revenue growth rate of 26.96% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 45.92%, and while it is forecast to beat the US market's average forecast revenue growth rate of 22.25%.
Zai Lab's revenue in 2026 is $460,156,000.On average, 11 Wall Street analysts forecast ZLAB's revenue for 2026 to be $582,744,772,313, with the lowest ZLAB revenue forecast at $502,131,929,878, and the highest ZLAB revenue forecast at $728,403,305,207. On average, 10 Wall Street analysts forecast ZLAB's revenue for 2027 to be $754,492,391,463, with the lowest ZLAB revenue forecast at $603,998,858,275, and the highest ZLAB revenue forecast at $939,837,757,436.
In 2028, ZLAB is forecast to generate $1,089,069,986,199 in revenue, with the lowest revenue forecast at $940,169,679,653 and the highest revenue forecast at $1,240,282,684,190.